SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Arbitrum is one of the leading Ethereum scaling solutions bringing cheap transactions to tens of thousands of users in an environment that feels very similar to Ethereum. It is an optimistic rollup and the leading L2 in terms of TVL. Some of the largest dApps live on Arbitrum include GMX, Radiant, Uniswap V3, and Gains Network.

Arbitrum

Traders are linking ARBs rally to Robinhoods tokenized-stock activity on Arbitrum and potential revenue from its chain, viewing the partnership as evidence of growing adoption. Others question whether that activity benefits ARB holders, citing weak token value capture and ongoing unlocks.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Kodiaks positive Phase 3 DAYBREAK results have intensified competition concerns in wet AMD and weighed on Ocular Therapeutix. Traders disagree on whether AXPAXLIs SOL-1 results and planned NDA filing can preserve its differentiation, particularly on durability, against Kodiak and other retinal treatments.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

AEROs sharp rally is being tied by traders to the anticipated AerodromeVelodrome merger and broader multichain expansion, which they see as a potential boost to liquidity and revenue beyond Base. The community is broadly bullish but debating whether momentum can clear psychological resistance or whether the move could fade into a pullback or sell-the-news reaction.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

PEPEs choppy, range-bound trading near a key round-number level is the main topic, with traders noting it has lagged some other crypto assets and that brief rebounds have often faded. Bulls see consolidation and support as signs of a possible breakout, while bears point to weak momentum, selling pressure, and repeated resistance tests.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobes quarterly results beat expectations, but the stocks reaction has been dominated by concerns about a softer near-term outlook, slowing recurring-revenue growth, and whether AI adoption will translate into durable paid growth. Traders are split between viewing Adobe as a cash-generative business whose AI products and customer base remain resilient and fearing that AI tools and free software clones could erode its creative-software moat; the CEO transition adds uncertainty.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Teva- Pharmaceutical Industries Ltd.

Teva- Pharmaceutical Industries Ltd. - ADR

FDA approval of WELTRUZA, Tevas once-monthly under-the-skin olanzapine injection for schizophrenia, is the main catalyst, with a U.S. launch expected in the coming weeks. Traders are highlighting its simpler administration versus the existing long-acting option and reacting positively to the growth potential and fresh 52-week highs, though some posts are simply bullish price speculation.

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.

Vaxcyte Inc

Vaxcytes VAX-31 met the primary endpoints in its pivotal Phase 3 OPUS-1 trial, with immune responses comparable to established pneumococcal vaccines and stronger responses on some additional serotypes. Traders are weighing that clinical win and future trial milestones against the companys large stock-and-convertible offering, dilution concerns, profit-taking, and sharp post-announcement volatility.

Sezzle, Inc. engages in the operation of a digital payment platform that enables bank-to-bank transfer of money between consumers and businesses. The company was founded by Charlie G. Youakim, Killian Brackey and Paul V. Paradis on January 4, 2016 and is headquartered in Minneapolis, MN.

Sezzle Inc.

Sezzle rose sharply despite TD Cowen trimming its price target while maintaining a Buy rating; traders focused on the retained rating and saw the revised target as supportive. The move fueled hopes for a rebound and speculation about short covering, though recent volatility and the post-earnings selloff remain concerns.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is drawing attention after its and Modernas personalized cancer-vaccine combination with Keytruda met Phase 3 recurrence-free and distant-metastasis-free survival endpoints in resected melanoma. Traders see the result as validation of Mercks oncology pipeline and a potential boost to the Keytruda franchise, while some question the rallys valuation because full trial data, overall-survival results and regulatory prospects remain uncertain.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers FDA approval of the Tukysa regimen for frontline maintenance treatment of HER2-positive metastatic breast cancer is drawing attention, alongside other positive pipeline updates and analyst upgrades. Bulls view the oncology progress as support for a recovery, while skeptics point to patent-expiration risks and difficulty sustaining a breakout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kraft Heinz is drawing attention as a deeply discounted, high-yield turnaround bet, with traders pointing to its new CEO, operational changes, and potential for a recovery after a prolonged share-price decline. Bulls are accumulating for the dividend and a possible rebound, while skeptics cite weak packaged-food fundamentals, ongoing price pressure, and uncertainty about whether management can revive growth.

Kraft Heinz Costs Less Than $22 a Share. Here's Why I'd Still Not Buy One.

Key PointsThe Kraft Heinz stock price has dipped 40% over the last five years...

Kraft Heinz (KHC) Rises As Market Takes a Dip: Key Facts

Kraft Heinz (KHC) closed at $22.48 in the latest trading session, marking a +2.27% move from the prior day.

HELE Q2 Earnings on the Horizon: Essential Insights for Investors

HELE's fiscal second-quarter results are likely to reflect revenue growth as brand momentum and digital initiatives offset demand and cost pressures.

These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Kraft Mac & Cheese Enters First New Category in Nearly 20 Years with Cheesy Ramen

Today, Kraft Mac & Cheese debuts Kraft Mac & Cheese Cheesy Ramen, marking the brands entry into a new category for the first time in nearly 20 years. Available in Spicy, Chicken and Pork varieties, the new lineup brings the familiar cheesy taste fans have loved for nearly 90 years to the ramen...

Will Kraft Heinz (KHC) Beat Estimates Again in Its Next Earnings Report?

Kraft Heinz (KHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

LW's Q1 Earnings Coming Up: Will the Surprise Streak Continue?

Lamb Weston's Q1 results may reflect cost and pricing pressures, though volume growth, market-share gains and efficiencies could have offered support.


Kraft Heinz vs. PepsiCo: Which Consumer Goods Stock Is a Better Buy in 2026?

Key PointsKraft Heinz is leveraging its Taste Elevation and Easy Ready Meals platforms while managing a significant turnaround effort...

Kraft Heinz (KHC) Declines More Than Market: Some Information for Investors

The latest trading day saw Kraft Heinz (KHC) settling at $22.72, representing a -3.11% change from its previous close.

Lunchables Fires Up National Pizza Month With the First-Ever Lunchables Pizza Grill

Lunchables is turning up the heat on a fan debate with the limited-edition Lunchables Pizza Grill, the first-ever device designed for heating up Lunchables Pizza. Debuting in honor of National Pizza Month, the Lunchables Pizza Grill invites fans to finally put one of the brands most spirited...

The Kraft Heinz Co. engages in the manufacture and market of food and beverage products. It operates through the North America and International geographical segments. The company was founded on July 2, 2015, and is headquartered in Pittsburgh, PA.

Kraft Heinz Co

Disney, Kraft Heinz Stocks Slip After Companies Announce Multi-Year Strategic Alliance

Equity

Bullish Sentiment

Track KHC stock price, charts, news and real-time market activity on Stocktwits. Join the KHC message board to follow investor discussions, retail trader sentiment, bullish and bearish signals around Kraft Heinz Co stock.

KHC Stock Price Today - Kraft Heinz Co News, Charts, Retail Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$22.27
Prev Close	$22.48
Open	$22.35
Dividend Yield	6.63%
50-Day Moving Average	$24.54
Beta	0.18
Avg. Volume	21.86M
PE Ratio	-7.78

52-Week High	$28.09
52-Week Low	$21.04
Market Capitalization	$26.41B
EPS (Annual)	-$4.93
Price to Book	0.73
Revenue Per Employee	$712,628.57

Feed

News

Sentiment

Earnings

Fundamentals

Info

KHC Fundamentals